Cost effective but unaffordable: an emerging challenge for health systems

Fairness in implementation would be the critical aspect of this policy.

As long as NICE implements their "imperfect" proposal in a fair manner, many people might come around to supporting it.

A condition/disease (eg breast cancer) which has significantly more lobbying power should be treated in the same manner as a condition which has less lobbying power (eg ovarian cancer).